Abstract:We read with great interest the article by Dr Mannelli and colleagues [ [1] Mannelli L. Kim S. Hajdu C.H. et al. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization. Preliminary experience. European Journal of Radiology. 2013; 82: 577-582 Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar ], “Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience”, which appeared in the April 2013 issue of European Journal of Radiology.

Pre-treatment Apparent Diffusion Coefficient is Imaging Biomarker for Prediction of Response to Chemoembolization in Hepatocellular Carcinoma.